معنويات المحللين بشأن Insulet Corporation

The average price target for Insulet Corporation (PODD) among Wall Street analysts will increase by at least 5% within 60 days following the bullish sentiment narrative publication.

Insulet Corporation (PODD) stock price will outperform the broader healthcare equipment sector (XLV ETF) by at least 8% within 120 days following the publication of bullish analyst sentiment articles.

Analyst consensus rating on Insulet Corporation (PODD) will remain at 'Buy' or equivalent positive rating for the next 90 days, with at least 70% of covering analysts maintaining bullish positions.